| Tybost 150 mg film-coated tablets EU/1/13/872/001-002 |
Cobicistat on silicon dioxide |
Gilead Sciences Ireland UC |
— |
| Tyedra 1500 micrograms tablet PA25435/001/001 |
Levonorgestrel micronized |
Maxmind Pharmaceutical GmbH |
Not marketed |
| Tyenne 162 mg solution for injection in pre-filled pen EU/1/23/1754/010-012 |
Tocilizumab |
Fresenius Kabi Deutschland GmbH |
— |
| Tyenne 162 mg solution for injection in pre-filled syringe EU/1/23/1754/007-009 |
Tocilizumab |
Fresenius Kabi Deutschland GmbH |
— |
| Tyenne 20 mg/mL concentrate for solution for infusion EU/1/23/1754/001-006 |
Tocilizumab |
Fresenius Kabi Deutschland GmbH |
— |
| Tygacil 50 mg powder for solution for infusion EU/1/06/336/01 |
Tigecycline |
Pfizer Europe MA EEIG |
— |
| Tyruko 300 mg concentrate for solution for infusion EU/1/23/1745/001 |
Natalizumab |
Polpharma Biologics S.A. |
— |
| Tysabri 150 mg solution for injection in pre-filled syringe EU/1/06/346/002 |
Natalizumab |
Biogen Netherlands B.V. |
— |
| Tysabri 300 mg concentrate for solution for infusion EU/1/06/346/001 |
Natalizumab |
Biogen Netherlands B.V. |
— |
| Tyvense 20 mg capsules, hard PA23211/005/001 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 30 mg capsules, hard PA23211/005/002 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 40 mg capsules, hard PA23211/005/003 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 50 mg capsules, hard PA23211/005/004 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 60 mg capsules, hard PA23211/005/005 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyvense 70 mg capsules, hard PA23211/005/006 |
Lisdexamfetamine dimesylate |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Tyverb 250 mg film-coated tablets EU/1/07/440/1-2 |
Lapatinib ditosylate monohydrate |
Novartis Europharm Limited |
— |
| Ucedane 200 mg dispersible tablets EU/1/17/1202/001-002 |
Carglumic acid |
Eurocept International BV |
— |
| Ultibro Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules EU/1/13/862/001-006 |
Indacaterol maleate, Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Ultomiris 1 100 mg/11 mL concentrate for solution for infusion EU/1/19/1371/003 |
RAVULIZUMAB |
Alexion Europe S.A.S. |
— |
| Ultomiris 300 mg/3 mL concentrate for solution for infusion EU/1/19/1371/002 |
RAVULIZUMAB |
Alexion Europe S.A.S. |
— |
| Ulunar Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules EU/1/14/917/001-006 |
Indacaterol maleate, Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| UNIPHYLLIN 200 mg Prolonged-Release Tablets PA23369/003/001 |
Theophylline |
Ennogen Healthcare (Europe) Limited |
Not marketed |
| UNIPHYLLIN 300 mg Prolonged-Release Tablets PA23369/003/002 |
Theophylline |
Ennogen Healthcare (Europe) Limited |
Not marketed |
| UNIPHYLLIN 400 mg Prolonged-Release Tablets PA23369/003/003 |
Theophylline |
Ennogen Healthcare (Europe) Limited |
Not marketed |
| Uplizna 100 mg concentrate for solution for infusion EU/1/21/1602/001 |
Inebilizumab |
Amgen Europe B.V., |
— |
| Upstaza 2.8 × 10^11 vector genomes/0.5 mL solution for infusion EU/1/22/1653/001 |
Eladocagene Exuparvovec |
PTC Therapeutics International Limited |
— |
| Uptravi 100 microgram film-coated tablets EU/1/15/1083/012-013 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 1000 microgram film-coated tablets EU/1/15/1083/007 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 1200 microgram film-coated tablets EU/1/15/1083/008 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 1400 microgram film-coated tablets EU/1/15/1083/009 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 1600 microgram film-coated tablets EU/1/15/1083/010 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 200 microgram film-coated tablets EU/1/15/1083/001-003 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 400 microgram film-coated tablets EU/1/15/1083/004 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 600 microgram film-coated tablets EU/1/15/1083/005 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 800 microgram film-coated tablets EU/1/15/1083/006 |
Selexipag |
Janssen-Cilag International NV |
— |
| Urorec 4 mg hard capsules EU/1/09/608/1-7 |
Silodosin |
Recordati Ireland Limited |
— |
| Urorec 8 mg hard capsules EU/1/09/608/8-14 |
Silodosin |
Recordati Ireland Limited |
— |
| Usgena 130 mg concentrate for solution for infusion EU/1/25/1987/005 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Usgena 45 mg solution for injection EU/1/25/1987/001 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Usgena 45 mg solution for injection in pre-filled syringe EU/1/25/1987/002 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Usgena 90 mg solution for injection in pre-filled syringe EU/1/25/1987/003-004 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Usrenty 130 mg concentrate for solution for infusion EU/1/25/1973/004 |
Ustekinumab |
Biocon Biologics Ireland Limited |
— |
| Usrenty 45 mg solution for injection EU/1/25/1973/001 |
Ustekinumab |
Biocon Biologics Ireland Limited |
— |
| Usrenty 45 mg solution for injection in pre-filled syringe EU/1/25/1973/002 |
Ustekinumab |
Biocon Biologics Ireland Limited |
— |
| Usrenty 90 mg solution for injection in pre-filled syringe EU/1/25/1973/003 |
Ustekinumab |
Biocon Biologics Ireland Limited |
— |
| Usymro 130 mg concentrate for solution for infusion EU/1/25/1957/004 |
Ustekinumab |
Gedeon Richter Plc |
— |
| Usymro 45 mg solution for injection EU/1/25/1957/001 |
Ustekinumab |
Gedeon Richter Plc |
— |
| Usymro 45 mg solution for injection in pre-filled syringe EU/1/25/1957/002 |
Ustekinumab |
Gedeon Richter Plc |
— |
| Usymro 90 mg solution for injection in pre-filled syringe EU/1/25/1957/003 |
Ustekinumab |
Gedeon Richter Plc |
— |
| Uzpruvo 130 mg concentrate for solution for infusion EU/1/23/1784/005 |
Ustekinumab |
Stada Arzneimittel AG |
— |